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Abstract: Pyrethroid resistance in major malaria vectors such as Anopheles funestus threatens malaria
control efforts in Africa. Cytochrome P450-mediated metabolic resistance is best understood for
CYP6P9 genes in southern Africa in An. funestus. However, we do not know if this resistance
mechanism is spreading across Africa and how it relates to broader patterns of gene flow across the
continent. Nucleotide diversity of the CYP6P9a gene and the diversity pattern of five gene fragments
spanning a region of 120 kb around the CYP6P9a gene were surveyed in mosquitoes from southern,
eastern and central Africa. These analyses revealed that a Cyp6P9a resistance-associated allele has
swept through southern and eastern Africa and is now fixed in these regions. A similar diversity
profile was observed when analysing genomic regions located 34 kb upstream to 86 kb downstream of
the CYP6P9a locus, concordant with a selective sweep throughout the rp1 locus. We identify reduced
gene flow between southern/eastern Africa and central Africa, which we hypothesise is due to the
Great Rift Valley. These potential barriers to gene flow are likely to prevent or slow the spread of
CYP6P9-based resistance mechanism to other parts of Africa and would to be considered in future
vector control interventions such as gene drive.
Keywords: resistance; Anopheles funestus; CYP6P9a gene; gene flow; Africa
1. Introduction
Anopheles funestus is one of the most important malaria vectors in Africa. The vector has a wide
geographic distribution ranging from south of the Sahara Desert to northern South Africa and
Madagascar [1]. In many of these areas, An. funestus is the dominant malaria vector, due to its highly
anthropophilic and endophilic preferences [2,3]. Sub-Saharan Africa where more than 90% of the
world-wide burden of malaria occurs, has witnessed unprecedented progress in malaria prevention and
control in the last two decades, with around a 70% reduction in malaria mortality [4]. This has mainly
been the result of a significant scaling up of vector-control interventions, relying extensively on the use
of insecticide-treated nets and residual spray inside houses [5–7]. Unfortunately, the propensity of
Anopheles mosquitoes to develop resistance to various types of insecticides is endangering these fragile
gains [8]. Resistance to pyrethroid insecticides is of particular concern because they are the main class
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of insecticide, with low toxicity to humans, that are currently recommended for impregnation into bed
nets [9]. This major challenge for control tools, highlights the urgent needs for a better understanding
of resistance evolution by assessing the speed and spread of resistance in major malaria vectors.
Resistance to pyrethroids has been reported in many populations of malaria vectors in the southern
part of Africa, notably in An. funestus [10–15]. Investigations of underlying resistance mechanisms
revealed that cytochrome P450-based metabolic resistance is the main mechanism involved in the
observed resistance [16,17]. Moreover, selective sweeps have been reported to be associated with this
metabolic resistance, driven by the scale-up of insecticide-based malaria control [18,19]. In the context
of insecticide resistance escalation [20], continuous monitoring of spread of resistance and selection
levels is necessary to predict control failure and recommend alternative insecticides. The tandemly
duplicated An. funestus cytochrome P450s CYP6P9a and CYP6P9b genes were identified as the main
drivers of resistance in Mozambique and southern Malawi [16,17,19], yet it remains unclear whether the
confinement of this mechanism to the southern part of Africa is due to unidentified phylogeographic
barriers to its spread, or insufficient time for continent-wide dispersion to occur. Significant genetic
structure has been previously revealed among An. funestus populations across Africa [18–21] in line
with pre-existing data [22]. It remains to be established how such population structure impacts the
spread of P450-based resistance, which is the predominant resistance mechanism in An. funestus.
Monitoring of the genetic diversity and signatures of selection on P450-based resistance loci, such as
that driven by CYP6P9a, is necessary to better understand the dynamic and evolution of such major
mechanism of resistance to insecticides in malaria vectors.
Here, we provide an overview of the genetic diversity and selection acting on the major pyrethroid
resistance gene CYP6P9a across southern and East Africa and infer the dynamics of the spread of this
resistance allele between the different mosquito populations. We confirm the presence of a strong
selective sweep spanning a 120 kb previously-identified major cytochrome P450-based pyrethroid
resistance locus [17,18] with a contrasting signature between regions highlighting the likelihood of
previously reported barriers to gene flow in this species.
2. Materials and Methods
2.1. Sampling
Anopheles funestus mosquitoes were collected between 2012 and 2018 from nine localities in
six countries in southern, eastern and central Africa (Figure 1). The sampling locations were:
Palmeira [20] and Magania-da-Costa in Mozambique (MOZ), Fulirwa in Malawi (MAL), Kaoma [21]
in Zambia (ZB), Muheza, Tulizamoyo and Ikwambi in Tanzania (TZ) [23], Tororo [24] in Uganda
(UG) and Kinshasa [25] in Democratic Republic of Congo (DRC). Further details are presented in
(Table S1). Additional analyses were performed using sequencing data accessions of mosquitoes from
Lagdo in Cameroon (CAM) reported in a previous study (Accessions KU168978 to KU168995) [18].
All mosquitoes were dissected into “ead and thorax” and “Abdomen” samples prior to DNA extraction.
Genomic DNA was extracted from each part of the mosquito using the Livak method [26] or the DNeasy
DNA extraction Kit (Qiagen Inc., Valencia, CA, USA). Head and Thorax samples were molecularly
identified as An. funestus using a cocktail PCR [27] and further confirmed where ambiguous with
primers targeting the internal transcribed spacer region 2 (ITS2) of ribosomal DNA as previously
described [27]. Only confirmed An. funestus sensu stricto (hereinafter referred to as An. funestus)
mosquitoes were used in this study.
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Figure 1. Map of Sub-Saharan Africa showing the sampling locations. Circle colour corresponds to 
sampling site colouring in the legend. 
2.2. PCR Amplification and Sequencing of CYP6P9a Gene and rp1 Fragments 
Nucleotide diversity in the CYP6P9a gene and the surrounding genomic region was assessed by 
PCR amplicon sequencing. Primers from Riveron et al. [16] were used to amplify a portion of the 5′ 
upstream intergenic region, the untranslated region, 1470 bp coding sequence of the two exons and 
the gene’s unique intron for a total length of ~2.2 kb [17]. Five additional loci spanning the 120 kb 
BAC region located in the resistance-to-pyrethroids 1 (rp1) quantitative trait loci (QTL) region of the 2R 
chromosome of An. funestus genome were also amplified in order to assess the presence of a selective 
sweep around CYP6P9a across Africa. These loci: 0 BAC, 25 BAC, 63 BAC, 95 BAC and 120 BAC were 
originally characterized in the laboratory resistant strain, FUMOZ-R, and are located at −34 kb, −9 kb, 
+29 kb, −61 kb and +86 kb upstream and downstream of the start of the CYP6P9a locus respectively 
[17,18]. For each rp1 fragment located upstream and downstream of CYP6P9a, one pair of primers 
previously published [18] was used to amplify fragments of genomic DNA approximately 700 bp 
long (Figure S1, Table S2). 
PCRs were performed by 15 μL amplification reaction consisting of 0.02 unit of Phusion Hot 
Start II High-Fidelity DNA Polymerase (Thermo Fisher Scientific, Waltham, MA, USA) for CYP6P9a 
and 1 unit of KapaTaq (Kapa Biosystems, Wilmington, MA, USA) for BAC clone. Reactions were 
added of 0.2 mM dNTPs, 0.5 μM of each primer, respective buffer solutions for GC rich templates 
and at least 10 ng of genomic DNA (1 μl). PCR reactions were carried out in PCR System 2720 thermal 
cycler (Applied Biosystems, Foster City, CA, USA) under the following conditions for CYP6P9a gene: 
1 min at 98 °C, followed by 35 cycles of 10 s at 98 °C, 30 s at 62 °C and 2 min at 72 °C and a final 
extension of 10 min at 72 °C. BAC fragments was amplified using a program of 5 min at 95 °C, 
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ucleotide diversity in the CYP6P9a gene and the surrounding geno ic region as assessed by
P a plicon sequencing. Primers from Riveron et al. [16] were used to amplify a portion of the
5′ upstream intergenic region, the untranslated region, 1470 bp coding sequence of the two exons
and the gene’s unique intron for a total length of ~2.2 kb [17]. Five additional loci spanning the
120 kb BAC region located in the resistance-to-pyrethroids 1 (rp1) quantitative trait loci (QTL) region
of the 2R chromosome of An. funestus genome were also amplified in order to assess the presence of
a selective sweep around CYP6P9a across Africa. These loci: 0 BAC, 25 BAC, 63 BAC, 95 BAC and
120 BAC were originally characterized in the laboratory resistant strain, FUMOZ-R, and are located at
−34 kb, 9 kb, +29 kb, −61 kb and +86 kb upstream and downstream of the start of the CYP6P9a locus
respectively [17,18]. For each rp1 fragment located upstream and downstream of CYP6P9a, one pair of
primers previously published [18] was used to amplify fragments of genomic DNA approximately
700 bp long (Figure S1, Table S2).
P s ere performed by 15 µL amplification reaction consisting of 0.02 unit of Phusion Hot Start
II High-Fidelity DNA Polymerase (Thermo Fisher Scientific, Waltham, MA, USA) for CYP6P9a and
1 unit of KapaTaq (Kapa Biosystems, Wilmington, MA, US ) for BAC clone. Reactions were added
of 0.2 mM dNTPs, 0.5 µM of each primer, respective buffer solutions for GC rich templates and at
least 10 ng of genomic DNA (1 µl). PCR reactions were carried out in PCR System 2720 thermal cycler
(Applied Biosystems, Foster City, CA, USA) under the following conditions for CYP6P9a gene: 1 min
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at 98 ◦C, followed by 35 cycles of 10 s at 98 ◦C, 30 s at 62 ◦C and 2 min at 72 ◦C and a final extension of
10 min at 72 ◦C. BAC fragments was amplified using a program of 5 min at 95 ◦C, followed by 35 cycles
of 30 s at 95 ◦C, 30 s at a primer-specific temperature (Table S2), and 1 min at 72 ◦C and, for a final
extension that lasted 10 min at 72◦C.
PCR products were purified using the EXOrSAP reagent (New England Biolabs, Ipswich, MA,
USA) or the QIAquick PCR Purification Kit (Qiagen) and directly sent for sequencing using PCR primers.
We designed additional internal overlapping primers (Table S2) for sequencing the CYP6P9a locus,
in order to ensure coverage of the full-length sequence. To ensure reliability of the sequencing data,
PCR amplicons were sequenced in both directions, and any remaining ambiguities in the sequences
resolved by repeated PCR amplification and re-sequencing.
2.3. Data Analysis
Sequence alignment was conducted with the ClustalW module of MEGA X version 10.1 [28].
Heterozygous sites in sequence data were phased using the PHASER algorithm implemented in DnaSP
version 6.12.01 (University of Barcelona, Barcelona, Spain) [29]. DnaSP was also used to identify the
number of segregating sites (S), levels of nucleotide diversity Pi (π), the average number of nucleotide
differences per site between any two sequence, and for testing deviations from neutrality at each locus
through Tajima’s D, Fu and Li’s D* and Fu’s FS indexes.
Haplotype analysis was conducted using DnaSP to count the number of haplotypes (h) and
the haplotype diversity (Hd) of each locus. TCS software [30] and its constituent program tcsBU
beautifier [31] were used to generate haplotype networks based on a 95% connection limit with gaps
treated as a fifth state. Haplotypes were labelled by colour and shape where the size of the shapes are
proportional to the frequency of the haplotype and space between circles on each branch show the
mutational steps separating haplotypes.
Phylogenetic trees generated by the Maximum likelihood (‘ML’) and Neighbour joining (NJ)
methods were inferred on CYP6P9a and BAC sequences using MEGA X. Before running ML trees,
final alignments were submitted to MEGA X Models program to select the best model for phylogenetic
analysis based on Bayesian and Akaike Information Criterions (BIC and AICc). The evolutionary
history of all sequences was derived using the Maximum likelihood method based on the Kimura
2-parameter (K2) or the Hasegawa-Kishino-Yano with γ distribution (HKY+G) models. The tree
with the highest log likelihood was selected. To test the robustness of tree topologies, 1000 bootstrap
replicates were performed. Trees were drawn to scale, with branch lengths measured in the number of
substitutions per site. For FST distance pairwise comparisons, Neighbor-Joining trees were generated
and optimal trees with bests sum of branch length were selected.
For protein coding sequences, 642 bp of the CYP6P9a gene and 750 bp of the 25 BAC fragment,
we calculated piN/piS ratios (non-synonymous polymorphism rate/polymorphism substitution rate)
between the different populations to investigate selection pressure on the gene. A piN/piS ratio
significantly greater than one implies positive selection, less than one implies purifying selection,
and a ratio of one indicates a selectively neutral locus.
We estimated genetic diversity in the different geographical populations by calculating population
differentiation indexes in DnaSP software. FST, the fixation index shows the overall differentiation by
measuring how likely, two homologous genes, randomly chosen in a subpopulation, result from a single
gene in the subpopulation [32–34]. GST although analogous to the previous, was calculated to double
check the FST values and verify the consistency of the results. GST, is a multi-allele generalization of
FST, which was defined as the relative difference between the expected heterozygosity of the whole
population and the mean expected heterozygosity of the individual demes [33,35]. The KST statistic
was used to estimate the levels of pair-wise genetic differentiation between populations in terms of the
relative number of shared alleles among the populations, without regard to their frequencies [33,36].
HST which is related to haplotype frequency was also calculated. HST is a differentiation metric which
weighs alleles by their population frequency [33]. High HST values increase with the addition of private
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alleles in a population while it will decrease when a given allele dominating in the population will
rise in frequency. Finally, NST has been calculated to take into account the phylogenetic relationships
between haplotypes, and to test the occurrence of a phylogeographic pattern in the dataset [33,34] as
an NST significantly greater than GST, implies a phylogeographic structure [37]. NST estimates were
associated with the number of migrations per generation (Nm) to help evaluate gene flow among
studied populations. The statistical significance of HST and KST estimates was assessed by permutation
of subpopulations identities and recalculating indexes 10,000 times as implemented in DnaSP 6.12.
3. Results
3.1. Sequence Diversity at CYP6P9a
Sequences were first examined across the entire 2.2 kb length of the CYP6P9a locus. After alignment
and assessment in MEGA X [28], a consensus sequence of 1139 bp length was obtained for
111 An. funestus field-collected mosquitoes from ten localities in seven countries (Mozambique (Palmeira
and Magania-da-Costa), Malawi (Fulirwa), Zambia (Kaoma), Tanzania (Muheza, Tulizamoyo and
Ikwambi), Uganda (Tororo), Democratic Republic of Congo (DR Congo, Kinshasa) and Cameroon
(Lagdo)) for which good sequence data were obtained. This included 465 bp of the partial 5′ upstream
intergenic region, 32 bp of 5′UTR and 642 bp of partial gene’s first exon. The examination yielded
84 single nucleotide polymorphisms (SNPs) and 6 insertions or deletions (Indels) in the 1.139 bp
region (Figure S2), of which 49 polymorphism sites (47 SNPs and 2 indels) were observed in Cameroon
and DR Congo and most were located in the non-coding region. Again, Southern African mosquito
populations and subpopulations displayed lowest polymorphic sites (0 to 4 in the coding region) while
the highest one was observed in Cameroon (16 segregating sites in the coding region) (Table 1).
Table 1. Nucleotide diversity and neutral test at CYP6P9a.
2n S h hd π D D * FS
Complete sequence fragment (1139 bp)
Mozambique_Palmeira 20 1 2 0.10 0.00009 −1.16 −1.54 −0.88
Mozambique_Magania 32 3 3 0.12 0.00016 −1.73 −2.73 * −1.71
Mozambique 52 4 4 0.11 0.00014 −1.86 * −3.43 ** −3.63 *
Malawi 28 7 8 0.59 0.00061 −1.84 * −1.46 −5.83 **
Zambia 20 3 3 0.28 0.00042 −1.16 −0.12 −0.29
Tanzania_Muheza 16 3 3 0.24 0.00033 −1.70 −2.20 −0.90
Tanzania_Tulizamoyo 24 3 3 0.24 0.00035 −1.26 −0.19 −0.50
Tanzania_Ikwambi 18 1 2 0.11 0.00010 −1.16 −1.50 −0.79
Tanzania 58 7 6 0.20 0.00027 −2.05 * −2.77 * −4.89 *
Uganda 18 9 6 0.56 0.00105 −1.92 * −2.11 −1.91
DR Congo 26 24 9 0.53 0.00200 −2.33 ** −2.90 ** −2.04
Cameroon 20 23 7 0.68 0.00304 −1.79 −1.93 0.44
Overall 222 84 39 0.61 0.01095 −0.42 −3.96 ** −0.53
Coding Region (642 bp)
Mozambique_Palmeira 20 1 2 0.10 0.00016 −1.16 −1.54 −0.88
Mozambique_Magania 32 3 3 0.12 0.00029 −1.73 −2.73 * −1.71
Mozambique 52 4 4 0.11 0.00024 −1.86 * −3.43 * −3.63 *
Malawi 28 2 3 0.27 0.00043 −0.97 0.82 −1.09
Zambia 20 0 1 0.00 0.00000 - - -
Tanzania_Muheza 16 3 3 0.24 0.00058 −1.70 −2.20 −0.90
Tanzania_Tulizamoyo 24 0 1 0.00 0.00000 - - -
Tanzania_Ikwambi 18 1 2 0.11 0.00017 −1.16 −1.50 −0.79
Tanzania 58 4 4 0.10 0.00021 −1.85 * −3.51 ** -3.84 *
Uganda 18 0 1 0.00 0.00000 - - -
DR Congo 26 6 4 0.22 0.00083 −1.96 * −2.52 * −1.19
Cameroon 20 16 6 0.62 0.00403 −1.58 −1.37 0.47
Overall 222 41 20 0.54 0.01328 0.54 −2.42 * 4.08 *
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Table 1. Cont.
2n S h hd π D D * FS
Non-Coding Region (497 bp)
Mozambique_Palmeira 20 0 1 0.00 0.00000 - - -
Mozambique_Magania 32 0 1 0.00 0.00000 - - -
Mozambique 52 0 1 0.00 0.00000 - - -
Malawi 28 5 6 0.39 0.00085 −1.86 * −2.30 −4.66 **
Zambia 20 3 3 0.28 0.00096 −1.16 −0.12 −0.29
Tanzania_Muheza 16 0 1 0.00 0.00000 - - -
Tanzania_Tulizamoyo 24 3 3 0.24 0.00081 −1.26 −0.19 -0.50
Tanzania_Ikwambi 18 0 1 0.00 0.00000 - - -
Tanzania 58 3 3 0.10 0.00034 −1.47 −0.45 −1.60
Uganda 18 9 6 0.56 0.00242 −1.92 * −2.11 −2.11
DR Congo 26 18 8 0.47 0.00353 −2.24 ** −2.61 * −2.07
Cameroon 20 7 6 0.45 0.00175 −1.84 * −2.46 * −2.70 *
Overall 222 43 28 0.54 0.00790 −1.34 −4.28 ** −6.63 **
Column headings: 2n: number of sequences; S: segregating sites; h: number of haplotypes; hd: haplotype diversity;
π: Nucleotide diversity (Pi); D: Tajima’s D; D*: Fu and Li’s D* statistic; FS: Fu’s FS test. (*) represent significant
results and level of significance: * = p ≤ 0.05; ** = p ≤ 0.01.
All sites in Mozambique presented similar patterns of low diversity with respectively 0.00009
and 0.00016 nucleotide diversity (π) found in Palmeira and Magania da Costa. Similarly, all sites in
Tanzania presented similar patterns of low diversity with π ranging from 0.00010 to 0.00033. Overall,
nucleotide diversity was lowest in both countries, Mozambique (0.00014) and Tanzania (0.00027),
compared to Zambia (0.00042), Malawi (0.00061) and Uganda (0.00109). Cameroon and DR Congo
displayed higher but comparable diversity (respectively 0.00200 and 0.00304) corresponding to their
geographical proximity (Table 1). Nucleotide diversity was highest in central African countries. These
results indicate that the diversity of CYP6P9a gene was lower in the Southern and Eastern African
countries surveyed, than in Central African. We observed the same pattern of nucleotide diversity
when focusing only on the coding and non-coding region of the analysed fragment, with the exception
of Uganda. Indeed, in all Southern African countries, the diversity remains very low compare to
central African one. In Uganda however, no polymorphism is noted in the coding region, while in the
non-coding region, the observed diversity is even higher than in Cameroon (Table 1).
Results of Tajima’s D tests were significantly negative in all mosquito populations and sub
populations, showing a deviation from neutrality (Table 1). This result is confirmed in both coding
and non-coding regions where, instead of having non-computed D—because of the absence of
polymorphism in the assessed population—Tajima’s D tests were also negative. Significant and
negative Fu and Li’s D* and Fu FS values are concordant with positive selection indicating a strong
selective sweep at this locus (Table 1). Sliding window analysis of the pattern of polymorphism across
CYP6P9a gene reveal a loss in diversity in the entire first exon of the gene in southern and eastern
African mosquito populations as highlighted by the sharp peak at around 400 bp in sequences from
central Africa (Figure 2a). These results also suggest strong selection at CYP6P9a, specifically in the
coding region of the gene. Notably, only few SNPs (7 of 41) in the first exon coding region of CYP6P9a
that occurred in Mozambique, Malawi, Zambia and Tanzania were non-synonymous (Figure S2).
To identify if this result is due to positive selection, pN/pS ratios were calculated between CYP6P9a
non-synonymous and synonymous site among the different countries. Ratios were much greater than
1.0 in DR Congo (1.62) suggesting strong positive selection of CYP6P9a resistance allele in the country.
In mosquito populations from Zambia and Mozambique however, purifying selection was observed as
shown by ratios values that were less than one (0.31 to 0.94 respectively). In other countries where
there is no synonymous and/or non-synonymous substitution, we were not able to calculate the ratio
(Table 2).
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Mozambique 153.47 1 0.007 488.53 3 0.006 0.94
Malawi 153.43 0 0.000 488.57 2 0.004 -
Tanzania 153.50 0 0.000 488.50 0 0.000 -
Zambia 153.53 2 0.013 488.47 2 0.004 0.31
Uganda 155.17 0 0.000 486.83 0 0.000 -
DR Congo 157.09 1 0.006 484.91 5 0.010 1.62
Cameroon 156.63 0 0.000 485.38 16 0.033 -
pN/pS < 1: Purifying selection; pN/pS > 1: positive selection; pN/pS = 1: Neutrality.
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bootstrap support), East Africa (UG; 98% bootstrap support) and Central Africa (DRC and CAM; 49% 
bootstrap support). (C) Haplotype network for non-synonymous nucleotide variants in CYP6P9a. 
Mosquito populations from MOZ, MAL, ZB and TZ form a defined clade from UG, DRC and CAM 
populations, and are dominated by a single Major haplotype. UG forms a distinct haplotype related 
to CAM and DRC populations that also form two distinct but related haplotypes. Haplotypes are 
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haplotype it represents. Lines connecting haplotypes and each node represent a single mutation. (D) 
Phylogenetic tree generated by the Neighbor-Joining method based on pairwise Fst distance obtained 
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Figure 2. Analysis of genetic diversity in CYP6P9a key pyrethroid resistance gene in An. funestus
populations across seven different African countries. (A) Sliding-window analysis of nucleotide
polymorphism (Pi) in Southern Africa (158 accessions), Eastern (46 accession) and Central Africa
(18 accessions). Pi was calculated for segments of 400 bp at 100 bp intervals. The black bar shows
CYP6P9a gene’s exon. (B) Maximum likelihood tree of the CYP6P9a gene sampled from throughout
Africa, showing clear geographical divergence between southern Africa (MZ, MAL, ZB and TZ;
99% bootstrap support), East Africa (UG; 98% bootstrap support) and Central Africa (DRC and CAM;
49% bootstrap support). (C) Haplotype network for non-synonymous nucleotide variants in CYP6P9a.
Mosquito populations from MOZ, MAL, ZB and TZ form a defined clade from UG, DRC and CAM
populations, and are dominated by a single Major haplotype. UG forms a distinct haplotype related to
CAM and DRC populations that also form two distinct but related haplotypes. Haplotypes are labelled
by colour and shape where the area of each circle is proportional to the frequency of the haplotype it
represents. Lines connecting haplotypes and each node represent a single mutation. (D) Phylogenetic
tree generated by the Neighbor-Joining method based on pairwise Fst distance obtained from 1139-bp
CYP6P9a gene, including 111 A. funestus sequences from seven African countries according to each
sample’s country of origin.
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3.2. Maximum Likelihood Phylogenetic Tree and Haplotype Network for CYP6P9a
Phylogenetic analysis further confirms the selection acting on CYP6P9a in southern Africa and
Tanzania where less diversity and divergence is observed, but not in other parts of the continent
where we had higher divergence among individuals of the same population (Figure 2b, Figure S3).
The maximum likelihood tree of the CYP6P9a full length fragment, as well as those based on
non-synonymous SNPs, coding and non-coding regions of the gene sampled throughout Africa,
shows a clear geographical divergence between mosquito populations from Southern Africa (MOZ,
MAL, ZB) along with Tanzania (TZ), Eastern (UG) and Central Africa (CAM, DRC). Mosquito
populations from Southern Africa plus Tanzania share the same cluster, while those from Uganda and
Central Africa form two distinct clades driven by the same branch (Figure 2b, Figure S3). Analysis of
the TCS haplotype network of CYP6P9a confirms profiles obtained with the ML tree. CYP6P9a from
MOZ, MAL, ZB and TZ form a defined clade from UG, CAM and DRC populations, dominated by
a single major haplotype (frequency of 118). UG forms a distinct haplotype related to CAM and
DRC also forming two distinct but related haplotypes with respect to their geographical proximity
(Figure 2c). When considering only Non-synonymous mutations, the trend is the same with however
UG, CAM and DRC forming three unrelated haplotypes (Figure S4).
3.3. Genetic Differentiation of the CYP6P9a Gene
Genetic differentiation among populations was tested using FST values, which show the overall
fixation index and NST values that show phylogeographic relation between haplotypes. An Nm value
associated with FST, reflecting the number of migrations, was also calculated to evaluate gene flow
among studied populations. FST values showed a very low genetic differentiation between southern
African and Tanzanian mosquito populations (FST = 0.02) and an associated high gene flow between
them (Nm = 10.87). There were higher levels of genetic differentiation among populations from Central
Africa and Uganda than when compared to those from southern Africa (FST = 0.53 to 0.97) (Tables S3
and S4). The same trend is observed when considering only coding or non-coding regions of analysed
sequences (Tables S3 and S4). These results were consistent with GST, KST and KST estimates, as well
as the Neighbour-Joining tree based on FST distance values (Figure 2d; Tables S3 and S4). Moreover,
NST values were significantly greater than GST values when comparing central, eastern and southern
African mosquito population each other. The same observation was made for populations from the
two central African countries (Cameroon and DR_Congo) but not for southern African populations
(Table S3). This result implies there is a phylogeographic structure between compared haplotypes
except those from southern Africa.
3.4. Selective Sweep Surrounding CYP6P9a
To assess the impact of selection at CYP6P9a, the extent of nucleotide polymorphism was
examined at five loci around the resistance gene, within the BAC genomic region spanning the rp1 QTL,
approximately 120 kb long (Figure S1). For better assessment of the nucleotide diversity, results were
further summarized by grouping samples into southern (MOZ, MAL, ZB, TZ), Eastern (UG) and
Central (DRC, CAM) Africa. Taking into account the phylogenetic and diversity results, Tanzania was
now considered along with southern African samples and Uganda was the only representative of
eastern Africa diversity.
The average nucleotide diversity (π) for southern African (plus Tanzanian) mosquito populations
was lower at all six loci including CYP6P9a gene locus compare to that of populations from central
Africa (Figure 3a and Figure S5). In Eastern Africa, absence of polymorphic sites was noted at the
25 BAC (−9 kb) locus while higher nucleotide diversities were observed at loci further away: 0.0018,
0.0011, 0.0012 and 0.0020 for loci 0BAC (−34 kb), 63BAC (+29 kb), 95BAC (+61 kb) and 120 BAC
(+86 kb) respectively (Figure 3a, Table 3). Analysis of mosquito populations from DR Congo and
Cameroon, revealed higher levels of polymorphism (ranging in average from 0.0016 to 0.0036 for
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all analyzed loci) across the rp1 genomic fragment (Figure 3a, Table 3). This was principally the
case in Cameroon with highest observed polymorphism levels in this study, ranging from 0.0030
to 0.0065 genetic diversity (Table 3, Figure S5). The relative levels of nucleotide diversity between
eastern-central and southern mosquito populations were also calculated across the rp1 genomic region
(Figure 3b, Figures S5 and S6a,b, Table S5).
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Figure 3. Nucleotide diversity survey at CYP6P9a and five loci around the pyrethroid resistance gene.
For each locus, nucleotide diversity was investigated by sequencing A. funestus samples from seven
sub-Saharan African countries. Results were further grouped samples into Southern, Eastern and
Central Africa respective to mosquito field population origin. Positions (kb) of sequenced regions
relative to CYP6P9a. (A) Levels of nucleotide diversity (π) for each African region. (B) Ratio of
nucleotide diversity at each locus between Eastern-Central and Southern Africa.
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A striking reduction in the relative nucleotide diversity is observed between Eastern/Central and
southern Africa (ratio ranging from 1.1 to 1.8) at loci from −9 kb to +86 kb, but markedly high at−34 kb
and CYP6P9a loci (4.84 and 4.96 respectively) (Figure 3b, Table 3 and Table S5). Overall, a considerable
change was seen from −34 kb to +86 kb (0 BAC to 120 BAC) around the CYP6P9a and CYP6P9b loci as
well as other P450s and esterase loci (Table S6) where a strong signature of positive directional selection
was observed in southern and to a lesser extend in eastern Africa. Taken together, these results support
a selective sweep having occurred around CYP6P9a resistance gene, extending at least 100 kb in length
in southern Africa.
Similar patterns were drawn from haplotype diversity measures. Average Hd values were lower
for southern African mosquito populations for four loci along from −34 kb to +86 kb (but not at locus
+29 kb) than for the CYP6P9a resistance gene locus. The same is true for eastern Africa. However,
in central Africa average Hd values were much higher across all six loci including the gene CYP6P9a
(Table 3). Tajima’s D tests were most often negatively significant, a signature of selection or population
expansion, for the CYP6P9a locus in southern and Eastern African countries, however at least one
locus has a significant Tajima’s D in each sampled location (Table 3).
Phylogenetic analyses of the five BAC fragment sequences from mosquito populations sampled
throughout Africa highlighted a reduced diversity across the entire 120 kb portion of the rp1 QTL
studied. Construction of maximum likelihood (“ML”) phylogenetic trees revealed reduced diversity
close to the CYP6P9a locus in the resistant populations of Mozambique, Malawi, Zambia and Tanzania.
Uganda and DR Congo plus Cameroon samples show different profiles, forming distinct clusters
(Figure 4a and Figure S7). The ML tree of the portions located −34 kb (0 BAC) and −9 kb (25 BAC)
upstream the CYP6P9a gene, as well as +29 kb (63 BAC) and +61 kb (95 BAC) downstream, show that
all the sequences from southern Africa (MOZ, MAL, ZB and TZ) are highly similar and belong to
a unique major haplotype while those from UG and CAM plus DRC forms two distinct haplotypes
(Figure S7a–d). The profile is a bit different +86 kb (120 BAC) far from the gene, 120 BAC sequence
analysis reveals a profile which is typically the same as the one of the loci −34 kb. The only difference is
the additional sequences from DRC mosquito populations that now cluster with the major haplotype
(Figure 4a). The phylogeny of the BAC fragments sampled throughout Africa show a clear geographical
divergence between southern Africa (MOZ, MAL, ZB and TZ) and eastern/central Africa (UG, DRC and
CAM): mosquito populations from southern Africa share the same cluster, while those from eastern
and central Africa form two distinct clades.
As for CYP6P9a, haplotype networks of the five up- and down-stream loci confirmed profiles
obtained with the ML tree. In general, Mozambique, Malawi, Zambia and Tanzania formed their own
cluster, with reduced genetic diversity shown by the fact that haplotypes from each country had no
mutational steps between them. Samples from Uganda and DR Congo plus Cameroon formed their
own clusters with few mutational steps between them for almost all of the BACs except for +61 kb
(95 BAC) and +86 kb (120 BAC) loci (Figure S8). The significant difference in the 95 BAC loci is the
small cluster (deriving from the major haplotype) formed by eleven sequences from Mozambique,
Zambia and Tanzania (Figure S8d). In the 120 BAC loci, the only change is the fact that DR Congo
sequences now cluster with the major haplotype (Figure 4b). From −34 kb to +61 kb (0 to 95 BAC)
around CYP6P9a a strong signature of positive directional selection was observed in southern as well
as in eastern but not in central Africa. This reduced haplotype diversity is shown by the presence
of a highly predominant haplotype MAL/MOZ/ZB/TZ only in southern and part of eastern Africa
(Figure 4b).
Genetic differentiations parameters revealed patterns that were similar to those of the resistance
gene CYP6P9a. A very low genetic differentiation associated with a high geneflow was observed
between southern African mosquito population. Populations from central and eastern Africa exhibited
lower levels of genetic differentiation and gene flow between them compared to those from southern
Africa (Figure S9, Tables S7 and S8).
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Figure 4. Analysis of genetic diversity across the rp1 pyrethroid resistance locus, example of the
120 BAC locus (A) Maximum Likelihood phylogenetic tree generated using the Hasegawa-Kishino
Yano plus γ distribution model inferred on a 633-bp fragment of the 120 BAC locus of 111 A. funestus
sequences from 7 sub-Saharan African countries. Each split is labelled with its bootstrap support
value from 1000 bootstrap replicates. The tree is drawn to scale, with branch lengths measured in the
number of substitutions per site. (B) Haplotype network for nucleotide variants in 120BAC fragments
sequences showing that DR Congo mosquitos cluster with southern African versus mosquitos from
Uganda and Cameroon.
4. Discussion
4.1. Ge etic Diversity and Selection on CYP6P9a
Insecticide resistance among malaria vectors is expanding across Africa, threatening the success
of malaria control methods. Continuous monitoring of the evolutionary patterns of vectors population
behaviour regarding insecticide-based interventions is thus of great importance. Selection of
insecticide-resistance variants has been shown to result in severe reduction of genetic diversity
at loci involved during multiple insecticide-based interventions in both public health and agricultural
sectors that have been conducted across Africa to control malaria vectors and crop pest insects [18,38].
CYP6P9a plays a key role in insecticide metabolic resistance in southern Africa in An. funestus [16,17,19]
but whether the CYP6P9a resistant variant gene and others P450 insecticide resistance mechanisms
remain confined to the southern part of Africa is an open question. In the present study, we sequenced
a fragment of CYP6P9a gene and different loci spanning this gene and others resistance genes (CYP6P9b,
CYP6P4a, CYP6P4b), in a panel of different An. funestus populations across Africa. The goal was to
establish the Africa-wide population structure of this major malaria vector, providing key evidence of
the contemporary response of mosquito populations to insecticide interventions.
4.2. Spread of Resistance in An. Funestus Populations Across Africa and Barriers to Gene Flow
We observed the predominance of one major haplotype made up of mosquito populations
from Mozambique, Malawi, Zambia and Tanzania; southern African countries plus one Eastern
African country. Taken together, our results support the possible presence of barriers to gene
flow among mosquito populations from these four countries on one side, and central (DR Congo,
Cameroon) and eastern (Uganda) African mosquito populations on the other. Based on phylogenetic
relationships, haplotype diversities, FST estimates and all other genetic differentiation indexes reported,
southern African plus Tanzania populations are genetically differentiated from other populations at
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the rp1 locus; among them, the resistance has spread and is now almost fixed. They always form
a unique cluster distinct from those formed by central and eastern African mosquito populations.
An. funestus mosquito populations from Mozambique and Malawi have previously been reported
to share similar genetic differentiation patterns [16,18,19,39–41]. Our data show the resistance allele
is fixed in southern Africa, and further highlights its expansion to Tanzania in eastern Africa where
gene flow was not observed between Uganda and Tanzania. The fixation of the resistance in southern
Africa is shown by the higher nucleotide diversity variability in CYP6P9a in Zambia in 2010 [40]
at 0.04 versus 0.00042 reported here, suggesting a reduced role in resistance in the country at that
time for this gene. We hypothesise that the presence of different geographical landforms like the
African Great Lakes, mountain ranges and the Rift Valley in the region, are responsible for the lack
of gene flow between southern Africa and other parts of the continent since the latter have been
already been shown to affect genetic population structure in the major malaria vectors An. funestus and
An. gambiae [42–44]. These patterns of genetic structure support the contrast in resistance patterns of
An. funestus population across Africa [11,13,16,18,24,40,45,46] and also give an indication on the speed
and the spread of the resistance on the continent. Indeed, the Rift Valley, if really a factor, may only
slow the spread of the CYP6P9a resistance variant and not prevent it completely. Further monitoring is
thus necessary especially since genome-wide microsatellite-based Bayesian clustering analysis data
recently revealed Ugandan An. funestus mosquito population clustering with those from southern
Africa, notably Mozambique and Zambia [47].
4.3. Pyrethroid Resistance in An. Funestus Is under Directional Selection
We confirmed a major selective sweep in the rp1 region which is one of the major pyrethroid
resistance QTL where P450 genes, including CYP6P9a, associated with metabolic pyrethroid resistance
have been identified [17,19]. Overall, multiple analyses provide evidence for a selective sweep
occurring in this QTL were supported by a reduction in the genetic variation in mosquito populations
from southern and part of eastern Africa (Figures 2–4; Table 1), of CYP6P9a key insecticide resistance
genes as well as others fragments from the BAC clone in the vicinity of the gene. It is important to
mention that these BAC fragments, in addition to overlap CYP6P9a gene locus, also covers genes like
CYP6P9b, CYP6P4a, CYP6P4b, located in the same rp1 region and that have already been identified to
play an important role in pyrethroid resistance in An. funestus [17].
4.3.1. CYP6P9a Resistance Allele Has Moved beyond Southern Africa into Eastern Africa
Strong directional selection acting on CYP6P9a was observed in Mozambique, Malawi, Zambia and
Tanzania, mirroring the predominant role of cytochrome P450 genes in the metabolic resistance
observed in An. funestus population as previously reported in southern Africa [16,40] and in other
mosquito species such as An. gambiae [48] and Aedes mosquitoes [29,49]. We found that almost
all SNPs in coding sequence of the first exon of CYP6P9a that occurred in Mozambique, Malawi,
Zambia and Tanzania were shared and non-synonymous (Figure S2), suggesting that CYP6P9a is under
positive selection in these four countries. The reduced haplotype diversity of CYP6P9a gene with
almost no mutational steps between the four countries is consistent with positive selection occurring.
The selection of this CYP6P9a has been shown to be metabolically more efficient in metabolising
pyrethroids [50], which may explain why pyrethroid resistance has been continuously associated with
a high overexpression of CYP6P9a and CYP6P9b genes in multiple An. funestus populations from
southern Africa [16,19,39,40,45]. However, the expression levels of key P450s such as CYP6P9a and
CYP6P9b varies between populations suggesting that independent selection events for resistance to
pyrethroids has occurred [41]. In this study, Cameroon, DRC and Uganda displayed higher diversity at
this locus, showing that this P450 resistance mechanism may play a lesser role in conferring pyrethroid
resistance to An. funestus population from these regions where CYP6P9a has also been reported to
be overexpressed but to at a lower level than southern Africa [24,29,40,41] as further supported by
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their higher genetic diversity in Uganda than in Malawi but also than in West (Benin and Ghana) and
Central Africa (Cameroon) [18].
Distinct genes associated with insecticide resistance, including the glutathione S-transferase GSTe2
and the Cytochrome P450 CYP9K1 genes, have been found to be more overexpressed in West/Central,
East Africa respectively [19,24,41,51]. Positive selection acting on CYP6P9a is similar to that of
GSTe2 conferring DDT (DichloroDiphenylTrichloroethane) resistance in An. funestus populations
West/Central Africa. A clear example is that provided by the resistant samples from Benin exhibiting
a GSTe2-derived resistant haplotype which is almost fixed while DDT susceptible populations remained
highly polymorphic at this locus in 2014 [51].
Patterns of genetic differentiation based on CYP6P9a showed southern African plus Tanzanian
mosquito populations to be significantly differentiated from populations from other regions. Again,
this pattern mimics the one of GSTe2 gene in west Africa and further supports the presence of barriers
to gene flow between southern Africa plus Tanzania on one side and Uganda plus Central Africa on
the other side. It is important to note that Tororo, the collection site in Uganda, is surrounded by
east and west branches of the African rift Valley and is located north of Lake Victoria on the border
with Kenya. The predominant CYP6P9a haplotype formed by southern African plus the Tanzanian
mosquito population was completely absent from the other countries in line with the low level of
gene flow observed between the two defined regions. This haplotype is a resistant allele similar to
a CYP6P9a resistant cluster from Mozambique and Malawi [16,18,40] that were shown to have an
increased efficiency to metabolise pyrethroids [40]. Indeed, insecticide-based interventions relying
mainly on LLINs and IRS implemented in these countries clearly impacted vector adaptation behaviour
leading to resistance selection [7,18,52,53].
In contrast to previous reports [13,18,40,41], the CYP6P9a resistance allele has moved from southern
Africa to part of eastern Africa but has not (yet) crossed the rift valley into Uganda. This contrasting
distribution mirrors the distribution of the GSTe2 resistance allele which is completely absent from
southern Africa and present in Uganda [51]. There is a need for a continuous monitoring of the
resistance spread across Africa to ensure the role of the rift valley playing a role in the observed
restriction to gene flow. Examples of resistance alleles that were initially confined within a certain
area before spreading beyond include the 296S resistant allele initially located only in West to East
Africa and completely absent from southern Africa in 2010 [46] that has now been detected in southern
Africa [15]. The same is true for knockdown resistance (kdr) mutations in other mosquito species such
as An. gambiae [54] or Ae. aegypti [55].
4.3.2. Reduced Polymorphism of the 120 kb rp1 Genomic Region Show a Selective Sweep in the
Vicinity of CYP6P9a
Polymorphism analysis of the rp1 QTL in An. funestus population across Africa found reduced
polymorphisms around CYP6P9a in almost all populations except in those from central Africa.
In general, the selection on the rp1 region appears to be more extensive in southern and parts of eastern
Africa in line with previous reports [16,18,53]. The reduced diversity that was observed in Mozambique,
Malawi, Zambia and Tanzania as well as the reduced haplotype diversity are due to a selective sweep
that was driven by effort to control the mosquito population as recently shown that a single cytochrome
P450 resistance allele (CYP6P9a_R) in An. funestus reduced the efficacy of insecticide-treated bed
nets in southern Africa [19]. In these four countries, selection is more pronounced in the vicinity of
CYP6P9a from −9 kb upstream the gene to +29 kb downstream, where lower levels of polymorphism
were recorded (Figure 3b). At loci +61 kb and +86 kb farther, low polymorphism was also observed
(Figure 3b). In the remaining locus, −34 kb (Figure 3a), the diversity was still lower compared to
other parts of Africa (but not reflected by the relative diversity results) showing that the region under
selection could be greater than the 120 kb region studied. This profile is attributable to the proximity of
the un-polymorphic loci to key P450 resistance genes and can be explained by the fact that in a situation
of near fixation of a selective sweep as seen in this study for southern and Tanzanian populations,
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directional selection is indicated by reduced genetic variation [56]. In eastern Africa, a similar selective
sweep profile was observed around −9 kb and +61 kb reflecting the different resistance profiles we
identified. In central Africa, except at the level of locus +86 kb where low polymorphism may indicate
selection of some kind, no selective sweep was observed. A locus encoding HEXIM 1/2 protein
(AFUN008365), overlaps +86 kb locus (Table S6). This protein’s function is not yet characterised in
An. funestus but has been reported to act as a transcriptional regulator which functions as a general RNA
polymerase II transcription inhibitor in humans [57,58]. One can thus hypothesise that AFUN008365
gene may play a certain role in resistance development in +86 kb locus. This result is in line with the
resistance patterns we described in the region. Based on haplotype networks, we showed a Kinshasa,
DRC An. funestus population that was clustering with the major resistant haplotype from southern
Africa at locus +86 kb (120 BAC), suggesting the arrival of a southern resistance allele in central Africa.
The resistance allele in question was not identified in Kinshasa, hence the possible existence of a further
barrier that crosses DRC. The polymorphism pattern at locus +86 kb in DRC could also be evocative
of the presence of a different resistance patterns occurring at this level as supported by the recent
characterisation of another resistance marker located in the 3L chromosomal region spanning the
rp3 QTL of An. funestus genome; the P450 pyrethroid metabolizer CYP9J11 gene which is commonly
overexpressed in all countries across Africa [41]. Since in southern Africa the region under selection
spans from −9 kb from CYP6P9a and beyond +86 kb, implying it is greater than the 120 kb region
studied, it is necessary to analyse chromosomal-level regions using the recently available An. funestus
genome assembly [59] to clearly demarcate the extent of this selective sweep.
5. Conclusions
This study provides evidence for the spread of a selective sweep on a cytochrome P450 responsible
for metabolic resistance to insecticides in the major malaria vector An. funestus. Through several
analytical approaches, our results show that the P450-based resistance mechanism is not confined to the
southern part of Africa but is now fixed there and has spread to Tanzania in eastern Africa. Our findings
are also supportive of the presence of barriers to gene flow between populations of An. funestus which
are likely to prevent or slow the spread of the CYP6P9-based resistance mechanism from southern
Africa to other parts of Africa. We identified that the rift valley region probably acts as a strong barrier
to gene-flow, stressing the importance of continuous monitoring of major vectors population structure
for vector control programmes. Finally, we highlight that, despite the heterogenous population
structure of An. funestus across Africa being favourable to resistance management, it will be a challenge
to the deployment of any genetic-based vector control approaches such as gene-drive mechanisms.
We provide vital information that should be taken into account in resistance monitoring as well as in
the implementation of novel vector control strategies that rely on populations intermixing freely.
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